They examined the expression levels of TCF7 in CD8+ T cells and found more tumor-infiltrating TCF7+ CD8+ T cells in ICB responders and more TCF7− CD8+ T cells in non-responders, demonstrating the predictive ability of TCF7 expression of CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.